Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 7:02 PM
Ignite Modification Date:
2025-12-24 @ 7:02 PM
NCT ID:
NCT02374957
Eligibility Criteria:
Inclusion Criteria:
* At least 35 years of age
* Atherosclerotic peripheral arterial disease
* Able to provide informed consent
* Lower extremity open or endovascular revascularization.
Exclusion Criteria:
* Known CHF (class III/IV)
* Allergic reaction to phosphodiasterase inhibitors
* Intracranial bleeding within 3 months or active bleeding peptic ulcer disease
* Traumatic vascular injuries requiring revascularization
* Pregnant or breast feeding women or women who plan to get pregnant over the study period
* Planned ipsilateral major amputation within 30 days of index procedure
* Moderate to severe hepatic impairment.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
35 Years
Study:
NCT02374957
Study Brief:
Protocol Section:
NCT02374957